The Alpine conference is a unique forum organised by the Cancer Drug Development Forum, that convenes every 18 months and gathers the leaders in the world of innovative cancer therapy development.
The 10th edition will take place from 26 to 28 February 2018, in Innsbruck, Austria.
This multi-stakeholder, interactive meeting will offer small group lectures with moderated discussions, plenary lectures including case studies and networking opportunities.
The programme will focus on the latest and future challenges with a special emphasis on biomarkers, cell therapy, rare cancers, patients’ reported outcomes, clinical trial design and horizontal drug development.
Who should attend?
Academics, regulators from European and international bodies, representatives from the pharmaceutical industry, policymakers, HTAs, and the patients’ advocacy community.
Why should you attend?
- To discuss the current and future challenges of innovative oncology drug development
- To address these highly relevant issues and their impact on the regulatory environment
- To benefit from small group lectures, interactive and moderated discussions, and plenary lectures including case studies
- To network with a multi-stakeholder audience of oncology experts.